Results 141 to 150 of about 919 (164)
Some of the next articles are maybe not open access.
Ocriplasmin for diabetic retinopathy
Expert Opinion on Biological Therapy, 2013Diabetic retinopathy is a serious public health concern. Vision impairment follows from intraocular vascular proliferation known as proliferative diabetic retinopathy (PDR) and/or from diabetic macular edema (DME). Clinical acumen and a recent meta-analysis of published studies suggest that the presence of a posterior vitreous detachment (PVD) reduces ...
Marc D, de Smet, Miguel, Castilla
openaire +2 more sources
OCRIPLASMIN FOR PHARMACOLOGIC VITREOLYSIS
Retina, 2012The vitreous may play an important role in the pathogenesis of various retinal disorders. Pharmacologic vitreolysis uses intravitreal pharmacologic agents to provide liquefaction of the vitreous and complete vitreoretinal separation. Ocriplasmin, a genetically engineered version of plasmin, has been shown in clinical trials to be able to safely release
openaire +2 more sources
The Efficacy and Safety of Ocriplasmin for Patients With Vitreous Macular Traction
Acta Ophthalmologica, 2022You-Xin Chen, Youxin Chen, Wen-Fei Zhang
exaly
Assessment of E. Coli Expression System for Overexpression of Active Recombinant Ocriplasmin
Advanced Pharmaceutical Bulletin, 2020Younes Ghasemi +2 more
exaly